# Segmed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/segmed

- Industry: Healthcare IT
- Headquarters: Palo Alto, US
- Website: www.segmed.ai
- Total disclosed funding: $23M
- Latest round: Series A (Sep 3, 2024)
- Investors on record: 17

## About

Segmed, Inc., based in the US, specializes in providing access to diagnostic-grade medical imaging data, essential for enhancing AI applications and clinical research across the life sciences and technology sectors.Founded in 2019 and headquartered in Palo Alto, US, Segmed, Inc. focuses on offering advanced imaging data for clinical applications. The company has completed 6 deals to date, with its most recent funding round being a Series A, raising USD 10.4 mn on September 3, 2024. The funding was co-led by iGan Partners and Advocate Health Care, among others, and the total amount raised stands at USD 10.4 mn. The firm was co-founded by Cailin Hardell, FSCCT Martin Willemink, Jie Wu, and W Koszek, with Cailin Hardell serving as the CEO.Segmed's core offerings revolve around providing access to de-identified diagnostic-grade medical imaging data, essential for advancing AI applications and clinical research. Their solutions include a real-world data (RWD) network that facilitates rapid discovery and investigational capabilities of imaging data, supporting early disease detection and enhancing operational processes for accessing therapeutic data ecosystems. Segmed serves clients from biotech and pharmaceutical sectors, academic institutions, and healthcare organizations across North America, Europe, and Asia, providing high-quality imaging data for research and regulatory needs.Segmed primarily generates revenue through subscription-based models, allowing clients access to their extensive database of regulatory-grade imaging datasets. Clients engage in B2B transactions, subscribing to various service tiers that provide access to specific datasets tailored to their research requirements. The revenue model involves partnerships with life sciences companies, enabling the use of Segmed's offerings for regulatory submissions and AI training, with pricing structures varying based on access level and dataset selection.Following their recent Series A funding of USD 10.4 mn in September 2024, Segmed plans to utilize the capital to expand its product offerings into additional biological fields. The company aims to enhance its market presence and is targeting expansion into new geographic regions, although specific markets have not been disclosed. This funding will support the development of new products designed to meet the evolving needs of their clientele.

## Funding rounds

- Series A, Sep 3, 2024, $10M — Blumberg Capital, Y Combinator, iGan Partners, Nova Capital, Nina Capital, Castellan Group, Bold Brain Ventures, Expeditions Fund, Advocate Health Care, Engine Health Capital, Fox Chase Partners
- Series A, Apr 30, 2024, $5.1M — Blumberg Capital, Y Combinator, Advocate Aurora Health, iGan Partners, Nova Capital, Nina Capital, Castellan Group, Bold Brain Ventures, Expeditions Fund, Fox Chase Cancer Center, Engine Health Capital
- Seed, Nov 15, 2022, $5.2M — M3, Inc., Alchemist Accelerator, iGan Partners, Mighty Capital, Nina Capital, Expeditions Fund
- Seed, Dec 2, 2020, $2M — Blumberg Capital, Nina Capital
- Seed, May 20, 2020 — Alchemist Accelerator, Voxel, Nina Capital

## Investors

- Alchemist Accelerator (https://capitalatlas.ai/funds/alchemist-accelerator) — Seed
- Voxel — Seed
- Nina Capital (https://capitalatlas.ai/funds/nina-capital) — Seed, Series A
- Blumberg Capital (https://capitalatlas.ai/funds/blumberg-capital) — Seed, Series A
- M3, Inc. — Seed
- iGan Partners (https://capitalatlas.ai/funds/igan-partners) — Seed, Series A
- Mighty Capital (https://capitalatlas.ai/funds/mighty-capital) — Seed
- Expeditions Fund (https://capitalatlas.ai/funds/expeditions-fund) — Seed, Series A
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Series A
- Advocate Aurora Health — Series A
- Nova Capital — Series A
- Castellan Group (https://capitalatlas.ai/funds/castellan-group) — Series A
- Bold Brain Ventures (https://capitalatlas.ai/funds/bold-brain-ventures) — Series A
- Fox Chase Cancer Center — Series A
- Engine Health Capital — Series A
- Advocate Health Care — Series A
- Fox Chase Partners — Series A